DINOTO, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 1.434
NA - Nord America 1.288
AS - Asia 1.251
SA - Sud America 246
AF - Africa 81
Totale 4.300
Nazione #
US - Stati Uniti d'America 1.235
RU - Federazione Russa 864
SG - Singapore 582
CN - Cina 213
IT - Italia 204
BR - Brasile 202
VN - Vietnam 152
HK - Hong Kong 119
GB - Regno Unito 74
DE - Germania 57
IE - Irlanda 47
KR - Corea 37
FI - Finlandia 34
CA - Canada 32
FR - Francia 31
IN - India 31
SE - Svezia 29
JP - Giappone 24
ZA - Sudafrica 22
AR - Argentina 20
NL - Olanda 18
TG - Togo 18
BD - Bangladesh 16
ID - Indonesia 16
BJ - Benin 15
PL - Polonia 15
IQ - Iraq 12
MX - Messico 12
AT - Austria 10
PK - Pakistan 8
TR - Turchia 8
UA - Ucraina 8
ES - Italia 7
NG - Nigeria 7
MA - Marocco 6
BE - Belgio 5
EC - Ecuador 5
LT - Lituania 5
PH - Filippine 5
CL - Cile 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
PE - Perù 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 3
LU - Lussemburgo 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
Totale 4.300
Città #
Singapore 324
Moscow 319
Ashburn 269
San Jose 223
Hong Kong 117
Dallas 91
Chandler 77
Verona 62
Ho Chi Minh City 57
Los Angeles 53
Beijing 47
Dublin 43
The Dalles 39
New York 38
Hanoi 35
London 29
Munich 23
São Paulo 23
Milan 22
Buffalo 19
Redondo Beach 19
Lomé 18
Tokyo 17
Montreal 16
Cotonou 15
Warsaw 15
Helsinki 14
Orem 14
Lappeenranta 13
Santa Clara 13
Phoenix 12
Johannesburg 11
Rome 11
Denver 10
Haiphong 10
Jakarta 10
Bologna 9
Da Nang 9
Frankfurt am Main 9
Council Bluffs 8
Mexico City 8
Naples 8
Poplar 8
Abuja 7
Chicago 7
Amsterdam 6
Atlanta 6
Cape Town 6
Chennai 6
Florence 6
Guangzhou 6
Houston 6
Kent 6
Lawrence 6
Princeton 6
Seattle 6
Stockholm 6
Toronto 6
Brasília 5
Brooklyn 5
Brussels 5
Campinas 5
Fortaleza 5
Kolkata 5
Nuremberg 5
Rio de Janeiro 5
Seoul 5
Sindelfingen 5
Washington 5
Baghdad 4
Belo Horizonte 4
Boston 4
Bắc Ninh 4
Casablanca 4
City of London 4
Columbus 4
Pescara 4
Tianjin 4
Treviso 4
Turku 4
Udine 4
Venice 4
Vienna 4
Xi'an 4
Bauru 3
Berlin 3
Bexley 3
Biên Hòa 3
Boardman 3
Delhi 3
Guayaquil 3
Hyderabad 3
Lahore 3
Lima 3
Manassas 3
Manchester 3
Mumbai 3
Nova Iguaçu 3
Paris 3
Santiago 3
Totale 2.442
Nome #
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 232
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 145
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 144
Autoimmune encephalitis misdiagnosis and mimics 142
Is there a correlation between MOGAD and SARS-CoV-2 infection? 141
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 131
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 128
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 124
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 122
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 118
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 117
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 114
Investigating the association between neoplasms and MOG antibody-associated disease 112
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 110
Autoimmune dementia 109
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 109
Fatigue in Multiple Sclerosis: a resting-state EEG microstate study 109
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 108
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses 102
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities 101
Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders 99
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 99
Complement activation profiles predict clinical outcomes in myelin oligodendrocyte glycoprotein antibody-associated disease 97
Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder 94
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses 90
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 90
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses? 87
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 87
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease 86
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder 81
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 81
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis 79
Neutropenia complicating anti-CD20 treatment in patients with multiple sclerosis: A retrospective case series and a systematic review of reported cases 79
Diagnosing an unusual case of myelitis and diabetes insipidus through skin biopsies 79
Treatment options in refractory autoimmune encephalitis 74
More efficient complement activation by Anti-Aquaporin-4 compared with Anti-Myelin Oligodendrocyte Glycoprotein antibodies 74
Serum Levels of Neurofilament Light Chain and Glial Fibrillary Acidic Protein Correlate with Disease Severity in Patients with West Nile Virus Infection 74
Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study 72
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 68
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 58
Autoimmune and paraneoplastic disorders of the nervous system 52
Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease 48
Epstein-Barr virus infection in patients with MOGAD 48
Unveiling Disability Accrual Mechanisms in AQP4-IgG-Positive NMOSD 32
Validation of the MOG-AR Score: A Retrospective Multicenter Study 15
Neuroglial markers of damage in autoimmune neurology 4
Totale 4.365
Categoria #
all - tutte 15.125
article - articoli 15.046
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 79
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 0 0 0 0 0 0 0 2 13 9 7
2022/2023236 6 18 13 32 18 69 4 15 32 6 13 10
2023/2024294 12 15 23 30 21 48 14 25 12 14 56 24
2024/2025856 48 27 34 121 48 44 49 50 136 71 88 140
2025/20262.948 184 160 144 517 920 168 290 204 218 143 0 0
Totale 4.365